Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

5.7%

3 terminated out of 53 trials

Success Rate

85.0%

-1.5% vs benchmark

Late-Stage Pipeline

9%

5 trials in Phase 3/4

Results Transparency

47%

8 of 17 completed with results

Key Signals

8 with results85% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (15)
Early P 1 (1)
P 1 (3)
P 2 (14)
P 3 (4)
P 4 (1)

Trial Status

Completed17
Recruiting15
Unknown10
Active Not Recruiting3
Terminated3
Not Yet Recruiting2

Trial Success Rate

85.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT02012699Recruiting

Integrated Cancer Repository for Cancer Research

NCT06641310Not ApplicableRecruitingPrimary

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

NCT03050268Recruiting

Familial Investigations of Childhood Cancer Predisposition

NCT05552755Phase 1RecruitingPrimary

Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

NCT05630794Phase 1Recruiting

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

NCT06557733Phase 2Recruiting

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

NCT05223036Phase 2Suspended

Testing Obeticholic Acid for Familial Adenomatous Polyposis

NCT04677998RecruitingPrimary

A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis

NCT04678011RecruitingPrimary

A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy

NCT05657145CompletedPrimary

Visualization of the Papilla Through Use of the NuView Device in Patients With FAP

NCT07199127Recruiting

Duodenal Polyposis Classification in FAP

NCT06578637Not ApplicableRecruiting

Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis

NCT06538402Not ApplicableRecruiting

Ten Versus Fifteen Centimeter Pouch in IPAA Surgery

NCT03494543Completed

Endoscopic Papillectomy for Ampullary Adenomas

NCT03471403RecruitingPrimary

Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis

NCT03847636Not ApplicableActive Not Recruiting

CryoBalloon Ablation for Treatment of Duodenal Adenomas

NCT06308445Phase 2Not Yet RecruitingPrimary

Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis

NCT06614738RecruitingPrimary

Microbial and Environmental Factors Associated with Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)

NCT04230499Phase 2Active Not RecruitingPrimary

Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

NCT05402891Phase 2CompletedPrimary

The CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous Polyposis

Scroll to load more

Research Network

Activity Timeline